Transgenomic ICEme Kits

Transgenomic has launched its ICEme Mutation Enrichment Kits for cancer biomarker research. The kits are based on the company's ICE COLD-PCR technology, which preferentially enriches mutant DNA sequences in an excess of wild-type DNA through selective amplification of the mutant DNA. The company said the kits are customizable, and the initial menu includes 17 clinically relevant, actionable mutations that are associated with important cancers.